Cite
MLA Citation
David E. Piccioni et al.. “Deferred use of bevacizumab for recurrent glioblastoma is not associated with diminished efficacy.” Neuro-oncology, vol. 16, no. 6, n.d., pp. 815–822. http://access.bl.uk/ark:/81055/vdc_100173696569.0x000016